Immunoprecise Antibodies Ltd IPA

Healthcare Biotechnology

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

NDAQ:IPA - Post by User

Immunoprecise Antibodies Ltd > Okay brilliant Earnings Call

<< Previous

Bullboard Posts

Next >>

Comment by Dragon1on Oct 21, 2022 10:13am

199 Views

Post# 35038626

RE:Okay brilliant Earnings Call

With the amout of insider buying and never any selling you would have to think that the level of confidence from management on the future development of products in the pipeline and acquisitions is on the verge of paying off.Remember how quickly the price shot up to $20 by just mentionning investments in the COVID vaccin,we just need some kind of concret news.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management